CCNA2 and cervical cancer: The antibody CAB000114 was used to detect CCNA2 at medium intensity with the proportion of stained cells < 25% in normal cervix tissue, and it showed high intensity staining in cervical cancer tissue, with the proportion of stained cells from 25 to 75%.